Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06654323 · ClinicalTrials.gov registry record · NA

The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity

A NA study of Childhood Obesity, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
2
Study locations

NCT06654323: Recruiting NA study of Childhood Obesity, sponsored by Vanderbilt University Medical Center.

NCT06654323 is a NA study of Childhood Obesity that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 900 participants, above the 540-participant average among 43 other Childhood Obesity trials with a reported enrollment target (67% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06654323, a NA study of Childhood Obesity, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
2
Study locations

Study Summary

The research team is recruiting 900 children between the ages 5-17 with obesity from Tennessee and Louisiana. The team is assigning children and their caregivers by chance to one of five groups. In the first group, 300 children and their caregivers receive 26 hours of IBT. In the second group, 300 children and their caregivers receive 13 hours of IBT. The remaining three groups of 100 children and their caregivers receive 16, 19, or 22 hours of IBT. Children's healthcare providers, nutritionists, and social workers are providing IBT to each of the groups over six months. At the start of the study and again after one year, the research team is measuring the children's body mass index, or BMI. BMI is a measure of a person's body fat based on their height and weight. The team is also looking at the children's: * Diet * Exercise * Sleep * Media use * Quality of life

Primary Outcome

The primary outcome is child body mass index (BMI) expressed as a percentage of the 95th percentile (%BMIp95) of the CDC growth curves.

Conditions Studied

Interventions

  • BEHAVIORAL Intensive Behavioral Lifestyle Modification

Study Locations (2)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2025-02-20
Est. Completion 2028-08-01
Phase NA

What NCT06654323 shows while recruiting

NCT06654323 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 540-participant average among 43 other Childhood Obesity trials with a reported enrollment target (67% higher).

The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which Intensive Behavioral Lifestyle Modification is the first listed.

NCT06654323 reports a single indexed study location in Louisiana, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06654323 about?

NCT06654323 is a clinical study titled "The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity". The research team is recruiting 900 children between the ages 5-17 with obesity from Tennessee and Louisiana. The team is assigning children and their caregivers by chance to one of five groups. In the first group, 300 children and their caregivers receive 26 hours of IBT. In the second group, 300 c...

What is the current status of trial NCT06654323?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-02-20. Estimated completion is 2028-08-01.

What conditions does trial NCT06654323 study?

This clinical trial studies the following conditions: Childhood Obesity.

What interventions are being tested in trial NCT06654323?

The interventions under investigation include: Intensive Behavioral Lifestyle Modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT06654323?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06654323 being conducted?

This trial has 2 study locations across Louisiana, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06654323's enrollment target sits among peer trials

900 7th of 43 higher than 37 of 43 other Childhood Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06654323, the US trial registry maintained by the National Library of Medicine. NCT06654323 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.